Drawing for TAUDX

USPTO serial 99687583

TAUDX

Reviewed by CopyMark Law Group

Status 802
Filing date
Status date
Registration date
—
Examiner
KHAN, AHSEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TAUDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Iverson

Lisa Iverson Iverson IP3642 N Racine Ave.Chicago, IL 60613United States

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases and neurological diseasesACTIVE—
044Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and neurological diseases; Medical diagnostic testing, monitoring and reporting services; medical testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 4, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 4, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2026DOCKASSIGNED TO EXAMINER—
Jul 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 6, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance